全文获取类型
收费全文 | 923篇 |
免费 | 76篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 38篇 |
妇产科学 | 24篇 |
基础医学 | 81篇 |
口腔科学 | 40篇 |
临床医学 | 61篇 |
内科学 | 300篇 |
皮肤病学 | 15篇 |
神经病学 | 55篇 |
特种医学 | 16篇 |
外国民族医学 | 1篇 |
外科学 | 120篇 |
综合类 | 26篇 |
预防医学 | 35篇 |
眼科学 | 78篇 |
药学 | 45篇 |
中国医学 | 1篇 |
肿瘤学 | 63篇 |
出版年
2023年 | 10篇 |
2022年 | 19篇 |
2021年 | 32篇 |
2020年 | 13篇 |
2019年 | 18篇 |
2018年 | 24篇 |
2017年 | 34篇 |
2016年 | 24篇 |
2015年 | 26篇 |
2014年 | 42篇 |
2013年 | 59篇 |
2012年 | 75篇 |
2011年 | 81篇 |
2010年 | 49篇 |
2009年 | 42篇 |
2008年 | 73篇 |
2007年 | 60篇 |
2006年 | 50篇 |
2005年 | 47篇 |
2004年 | 38篇 |
2003年 | 33篇 |
2002年 | 23篇 |
2001年 | 10篇 |
2000年 | 20篇 |
1999年 | 7篇 |
1998年 | 4篇 |
1997年 | 4篇 |
1996年 | 3篇 |
1993年 | 2篇 |
1992年 | 9篇 |
1991年 | 4篇 |
1990年 | 4篇 |
1988年 | 14篇 |
1986年 | 1篇 |
1984年 | 2篇 |
1983年 | 2篇 |
1981年 | 2篇 |
1980年 | 1篇 |
1978年 | 3篇 |
1977年 | 3篇 |
1976年 | 1篇 |
1975年 | 3篇 |
1974年 | 2篇 |
1973年 | 1篇 |
1972年 | 4篇 |
1969年 | 7篇 |
1968年 | 5篇 |
1967年 | 4篇 |
1966年 | 2篇 |
1964年 | 1篇 |
排序方式: 共有1002条查询结果,搜索用时 0 毫秒
1.
2.
Ping L. Zhang Sayeed K. Malek Jeffery W. Prichard Fan Lin Taher M. Yahya Michael S. Schwartzman Ruth P. Latsha Evan R. Norfolk Thomas M. Blasick Mingyue Lun Robert E. Brown James E. Hartle Santosh Potdar 《American journal of transplantation》2005,5(3):604-607
Campath-1H has been used successfully for induction and has resulted in a low rate of acute cellular rejection (ACR) in renal transplantation in combination with various postoperative immunosuppression regimens. This study was undertaken to investigate the extent of monocyte involvement in ACR, with or without Campath-1H induction. We found that monocytes represented the majority of inflammatory cells in grades Ib or higher ACR, but not with Ia type of ACR, regardless of the status of Campath-1H induction. Cases of ACR, following Campath-1H induction, appear to demonstrate a 'pure form' of monocytic ACR, whereas monocytes were mixed with many other types of inflammatory cells in the cases of ACR in the absence of Campath-1H induction. In addition with Campath-1H induction, the cases of monocyte-predominant ACR were found to uniformly exhibit a good response to corticosteroid treatment. We conclude that monocyte-predominate ACR may represent a severe form of rejection, with or without Campath-1H treatment. 相似文献
3.
4.
Abdul Rahman D El Kinge Rami A Mahfouz Ali I Shamseddine Ali T Taher 《Blood coagulation & fibrinolysis》2007,18(6):577-579
Recombinant activated factor VII has been Food and Drug Administration approved to treat hemorrhages in hemophiliac patients with inhibitors and in acquired hemophilia patients. Recombinant activated factor VII use has also been considered for the management of uncontrolled bleeding in a number of congenital and acquired hemostatic abnormalities. The myeloproliferative disorders are a group of clonal hematologic diseases where, frequently, abnormal platelet function is considered a hallmark. This is the first case report addressing the clinical benefit of off-label use of recombinant activated factor VII in an attempt to control intractable bleeding in a patient with a myeloproliferative disorder after splenectomy. 相似文献
5.
6.
Objective of present study is to evaluate the possible role of clopidogrel in improving glycemic indices and oxidative stress in patients with type 2 diabetes.This study was performed on 42 uncontrolled type 2 diabetic patients at the specialized center for Endocrinology and Diabetes, Al-Rasafa Directorate of Health, Baghdad. All of the patients were treated with (glibenclamide 5 mg at morning) and randomized into two groups: the first group includes 22 patients treated with clopidogrel tablets (75 mg/day) for 2 months; the second group includes 20 patients treated with a placebo formula (sodium bicarbonate 200 mg/day) for the same period. Treatment with clopidogrel produced significant improvement (P < 0.05) in fasting serum glucose (FSG), fasting serum insulin level, quantitative insulin sensitivity check index (QUICKI); and oxidative stress markers: serum malondialdehyde (MDA) and serum reduced glutathione (GSH) compared to their baseline levels. There was significant elevation (P < 0.05) in both FSG and fasting serum insulin and the MDA level with significant reduction (P < 0.05) in QUICKI of placebo group compared to their baseline levels. However, clopidogrel produced significant elevation (P < 0.05) in AST and ALT levels but placebo formula caused no significant alteration (P > 0.05) in the serum levels of these two enzymes.In conclusion the treatment with clopidogrel improved glycemic indices and reduced oxidative stress in patients with type 2 diabetes. 相似文献
7.
8.
9.
10.